161 related articles for article (PubMed ID: 29788649)
1. Reimbursement and coverage challenges associated with bringing emerging molecular diagnostics into the personalized medicine paradigm.
Ridge JR
Per Med; 2006 Aug; 3(3):345-348. PubMed ID: 29788649
[TBL] [Abstract][Full Text] [Related]
2. Personalized Medicine's Bottleneck: Diagnostic Test Evidence and Reimbursement.
Cohen JP; Felix AE
J Pers Med; 2014 Apr; 4(2):163-75. PubMed ID: 25563222
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing coverage and reimbursement: a provider's dilemma.
Logue LJ
Clin Leadersh Manag Rev; 2003; 17(6):346-50. PubMed ID: 14692079
[TBL] [Abstract][Full Text] [Related]
4. The current status and future potential of personalized diagnostics: Streamlining a customized process.
Richmond TD
Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
[TBL] [Abstract][Full Text] [Related]
5. Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States.
Frueh FW
Value Health; 2013; 16(6 Suppl):S27-31. PubMed ID: 24034309
[TBL] [Abstract][Full Text] [Related]
6. Coding, coverage, and compensation for pathology and laboratory medicine services.
Weiss RL
Clin Lab Med; 2007 Dec; 27(4):875-91, viii. PubMed ID: 17950903
[TBL] [Abstract][Full Text] [Related]
7. US FDA and personalized medicine: in vitro diagnostic regulatory perspective.
Težak Ž; Kondratovich MV; Mansfield E
Per Med; 2010 Sep; 7(5):517-530. PubMed ID: 29776248
[TBL] [Abstract][Full Text] [Related]
8. The current status of local medicare payment policy: how specialty societies can influence local coverage determinations.
Allen B; Pennington A; Keysor KJ
J Am Coll Radiol; 2008 Jun; 5(6):727-36. PubMed ID: 18514952
[TBL] [Abstract][Full Text] [Related]
9. CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY.
Chambers JD; Chenoweth MD; Pyo J; Cangelosi MJ; Neumann PJ
Int J Technol Assess Health Care; 2015 Jan; 31(5):347-54. PubMed ID: 26750558
[TBL] [Abstract][Full Text] [Related]
10. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
O'Donnell JC
Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
[TBL] [Abstract][Full Text] [Related]
11. Modernizing US regulatory and reimbursement policy to support continued innovation in genomic pathology.
Walcoff SD; Pfeifer JD
Per Med; 2012 May; 9(3):295-308. PubMed ID: 29758795
[TBL] [Abstract][Full Text] [Related]
12. Reflections on market access for personalized medicine: recommendations for Europe.
Payne K; Annemans L
Value Health; 2013; 16(6 Suppl):S32-8. PubMed ID: 24034310
[TBL] [Abstract][Full Text] [Related]
13. Sipuleucel-T (Provenge(®))-Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention.
Jarosławski S; Toumi M
BioDrugs; 2015 Oct; 29(5):301-7. PubMed ID: 26403092
[TBL] [Abstract][Full Text] [Related]
14. How hospitals confront new technology.
Coye MJ; Kell J
Health Aff (Millwood); 2006; 25(1):163-73. PubMed ID: 19787843
[TBL] [Abstract][Full Text] [Related]
15. Value-based interventional pain management: a review of medicare national and local coverage determination policies.
Manchikanti L; Falco FJ; Benyamin RM; Helm S; Singh V; Hirsch JA
Pain Physician; 2013; 16(3):E145-80. PubMed ID: 23703416
[TBL] [Abstract][Full Text] [Related]
16. Current Policy Challenges in Genomic Medicine.
Klein RD
Clin Chem; 2020 Jan; 66(1):61-67. PubMed ID: 31699701
[TBL] [Abstract][Full Text] [Related]
17. Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2003 and inclusion of registered nurses in the personnel provision of the critical access hospital emergency services requirement for frontier areas and remote locations. Final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2002 Dec; 67(251):79965-80184. PubMed ID: 12510665
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payers.
Graf MD; Needham DF; Teed N; Brown T
Per Med; 2013 May; 10(3):235-243. PubMed ID: 29768740
[TBL] [Abstract][Full Text] [Related]
19. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
[TBL] [Abstract][Full Text] [Related]
20. Financial impact of emergency department ultrasound.
Soremekun OA; Noble VE; Liteplo AS; Brown DF; Zane RD
Acad Emerg Med; 2009 Jul; 16(7):674-80. PubMed ID: 19549014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
